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The ICTS Center for Biomedical Informatics
(CBMI) offers industry-standard hardware infrastructure and software tools to store, integrate,
query, analyze, and visualize complex clinical and
molecular data sets. Director Rakesh Nagarajan,
MD, PhD, Assistant Professor of Pathology & Immunology, has successfully assimilated the infrastructure and personnel to support investigators in
managing their clinical and translational research
data through ClinPortal and tissue samples
through caTissue Suite.
ClinPortal allows investigators and study coordinators to describe the data capture components
of a clinical study using controlled vocabularies.
For example, drop-down menus containing data
entry options can be defined by the investigator.
ClinPortal then automatically generates the backend database schema as well as the forms to
enter the data and conduct queries. Using this
tool, data for clinical studies can be managed
without IT personnel intervention.
Although additional setup time may be necessary to map the data for a specific study to the
controlled vocabularies in ClinPortal, the advantages are well worth the effort for several reasons:
By default, data stored in ClinPortal is available
for sharing while following all HIPAA regulations,
although the investigator that owns the data
may turn off sharing if so desired. As a result,
once an investigator has established their study
within the ClinPortal system, there is potential
for sharing relevant data with and from other
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studies.
Data access is controlled both by regulatory (ex.
IRB) and investigator permissions.
Future phases include automated access to clinical data from systems such as ClinDesk and
TouchWorks. Assuming appropriate release by
the patient and access rights for the researcher,
investigators using ClinPortal will eventually have
access to clinical data for their study participants.
Tissue Suite, a web-based biospecimen inventory, tracking, and annotation tool, may be used for
study-based biospecimen collection efforts and by
other non-study investigators interested in identifying existing biospecimens throughout the medical
campus that may be available for translational research. The ICTS Translational Pathology and Molecular Phenotyping (TPMP) Core supports the
physical storage of biospecimens while caTissue
Suite is the application supported by both the CBMI
and the TPMP to provide the informatics to manage
data about those biospecimens. Investigators who
are managing their own biospecimen collection
efforts outside of the TPMP Core may still make use
of the caTissue Suite application to manage their
inventory with caBIG-compliant standards.
Web accessibility, the ability to share biospecimens and biospecimen-related data, advanced
search functionality, and capture of clinical, pathological, and quality assurance data for collected
(Please see ClinPortal: page 4)

DIRECTOR

DR. KENNETH S. POLONSKY
The ICTS has recently reached its one year anniversary, and since we are a relatively new program, some investigators have not yet realized the
benefit of ICTS membership. As a registered ICTS
member you have access to our various Cores and
services. For example, the Research Design and
Biostatistics Group provides FREE consultations
on protocol development. Services provided by
specialized Cores such as Human Imaging Unit
and the Brain, Behavior and Performance Unit are
subsidized by the ICTS.
Members can also apply for funding through the
ICTS Funding Programs. We rolled out the BJHF/
ICTS Clinical and Translational Research Funding

Program in September and we are now pleased to
be able to offer 2 additional opportunities. The Just
-In-Time Core Usage Funding Program is designed
to give investigators quick access to smaller dollar
amounts for ICTS Core usage and the Bander Business Ethics in Medical Research Funding Program
is intended to fund specialized research concerning
business ethics.
While we have accomplished much in one year,
we still have many opportunities ahead of us to
help advance clinical and translational research
activities. Access our website or contact our Administrative Core (icts@im.wustl.edu) to see how
the ICTS can support your research efforts.
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RECRUITMENT ENHANCEMENT CORE:
RECRUITMENT ACTION PLAN
“Health Care BandAids: How to Fix
America’s Ailing
Health Care System”
Lecture by
Ezekiel Emmanuel
NIH Dept of Bioethics

November 6
See attached flyer

Proposals for the
BJHF/ICTS RFA are
due by 5 pm, Monday,
November 17.

BY CHARLES RATHMANN

With the goal of providing a metrics-driven
recruitment methodology that delivers consistent
dependable outcomes and bolsters campus-wide
enrollment in Washington University clinical trials, the ICTS Recruitment Enhancement Core
(REC) has developed and tested a highly successful recruitment paradigm. This paradigm involves
creative brainstorming and best practice sharing
between a REC recruitment specialist and the
study team to determine how the study population may be attained. From this session, a studyspecific Recruitment Action Plan is developed
and implemented. The study plan outlines action
items with associated timeline and accountability
for each. This approach fosters collaboration
and clarity of goals and responsibilities while
giving each member of the study team a heightened sense of accountability and accomplishment. Additionally, the REC recruitment specialists continually search for new recruitment venues and opportunities to better assist PIs in hitting their enrollment targets.
The REC piloted the recruitment paradigm in
25 different trials over three main therapeutic
areas, specifically pulmonary/critical care, human nutrition and neurology. As of November
2007, after 12 months of measurable data, 664
potential participants were enrolled into the REC
pilot trials. This number translates into an
achievement of 125% of the enrollment target.
By contrast, the data captured in a previous En-

rollment Enhancement Project showed that the
median trial protocol was achieving only 60% of
the target enrollment goal for all Washington
University studies that were closed in 2005.
This vast improvement in enrollment suggests
that the proactive, targeted and collaborative
recruitment methods being used by the REC can
have a positive impact on achieving enrollment
goals.
A few takeaways from the REC pilot:
Having a Recruitment Specialist on a trial or
group of trials within a department offers a
tremendous return on investment, from an
enrollment standpoint.
It should come as no surprise that no two
trials are the same. Even trials that are similar in protocol or potential participant population can be drastically different in which recruitment methods foster the greatest return.
You have never exhausted all avenues for
recruitment – there are always more ways
and they don’t always need funding!
For more information on how the REC can assist
you, please contact Charles Rathmann at 314362-0897.

ICTS FUNDING PROGRAMS
“Best Practices in
University Technology
Transfer”
Special Address and
Open Forum by
Katharine Ku
Stanford University

November 24
See attached flyer

BU S I N E S S ET HI C S & C OR E US AGE
The ICTS announces two additional funding opportunities to complement the BJHF/ICTS Clinical
& Translational Research Funding Program.
Bander Business Ethics in Medical Research
Funding Program
The intent of this program is to promote innovative research that examines an ethical issue arising from the business or financial dimension of
medical research, especially insofar as this dimension affects the quality of research or the well
-being of patients enrolled in clinical trials. Anticipated awards will range from $10,000 and
$20,000 for 1 year. One or 2 proposals will be
funded in 2008.
Just-In-Time (JIT) Core Usage Funding Program
This program is intended to provide quick access
to funding to use the ICTS Cores for research

advancing medical knowledge that can improve
human health. A Letter of Support from the
Director of the ICTS Core that will provide the
requested service(s) is an essential part of the
application and must corroborate the service(s)
to be provided and the scientific relevance of
the research. Applicants may request up to
$10,000 for up to 1 year for use of ICTS Core
services. Applications will be accepted on a
monthly basis with an initial due date of December 10, 2008. The ICTS expects to make
available approximately $100,000 for this program annually.
Deadlines, complete instructions and application forms for both of these programs are now
available on the ICTS website.
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― H E A LT H C A R E B A N D - A I D S : H O W T O F I X
A M E R I C A ' S A I L I N G H E A LT H C A R E S Y S T E M ‖ .
The ICTS Bander Program in Business Ethics in
Medical Research is pleased to welcome Ezekiel
Emanuel, MD, PhD, for our first Bander Lecture
on November 6. Dr. Emanuel’s lecture is entitled
―Health Care Band-Aids: How to Fix America's
Ailing Health Care System‖. The lecture will be
held at 6 pm in Clopton Auditorium (lower level of
Wohl Clinic at Washington University School of
Medicine). Appetizers will be served at 5:15 pm.
An RSVP will be appreciated but is not required.
Please reply to Mary Favazza at
mfavazza@im.wustl.edu or 454-8224.
Dr. Emanuel is the Chair of the Department of
Bioethics at the National Institutes of Health, and
an internationally known bioethicist and breast
oncologist. He graduated from Amherst College in
1979, and received his M.Sc. from Oxford University in Biochemistry. He received both his MD and
his PhD in political philosophy from Harvard University. In 1987-1988, he was a fellow in the
Program in Ethics and the Professions at the
Kennedy School of Government at Harvard. He
completed his internship and residency in inter-
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nal medicine at Boston’s Beth Israel Hospital
and completed an oncology fellowship at the
Dana-Farber Cancer Institute, where he later
joined the faculty. He has published extensively
on the ethics of clinical research, advance care
directives, end of life care issues, euthanasia,
health care reform, the ethics of managed
care, and the physician-patient relationship. In
addition to receiving numerous distinguished
awards, he served on President Clinton’s
Health Care Task Force, on the National Bioethics Advisory Commission (NBAC), and on the
bioethics panel of the Pan-American Healthcare Organization.
Dr. Emanuel has also published multiple
books, including his latest Healthcare, Guaranteed: A Simple, Secure Solution for America, in
which he outlines his innovative approach to
comprehensive healthcare system reform, an
approach he developed together with Victor
Fuchs, professor of Economics at Stanford
University.

HAPPENED LAST MONTH?

HIGHLIGHTS

FROM

OCTOBER

-October 14: Center for Clinical Research Training
Career Development Seminar Series, ―NIH Public
Access Policy‖ by Cathy Sarli, MLS, and ―Basic
Functions of Endnotes‖ by Kim Lipsey, MLS.

pact is a national coalition of more than 1,100
college and university presidents dedicated to
promoting community service, civic engagement and service-learning in higher education.

-October 18: Center for Community-Based Research Linda Cottler, Ph.D., professor of epidemiology in psychiatry, Catina O’Leary, project manager
and Amy Hepler, research patient coordinator, gave
a presentation entitled "The Washington University
Center for Community-Based Research: A Model for
the Successful Integration of Community, Service
and Research" at the Missouri Campus Compact
conference Saturday, October 18. Campus Com-

-October 29: (12-4:30 PM) Center for Clinical
Research Training, Research Training Symposium and Poster Session. Located in the Farrell Learning & Teaching Center, the symposium included oral presentations and a poster
session showcasing research projects performed by junior faculty, fellows, and students
in Washington University School of Medicine
research training programs.

EVENTS & ANNOUNCEMENTS
- November 6: (4 – 5 pm): Human Imaging Unit: Dr.
Juhani Knuuti, MD, PhD will give a presentation
―Multi-tracer and Multimodal Imaging Services for
Pharma: Experiences at Turku PET Centre‖ in the
Scarpellino Auditorium, MIR Building. See attached
flyer for additional information.
-November 6: (6:00—7:00 pm) ICTS Bander Lecture. See article above for details.
-November 24 (3:00—5:30 pm): Business Development Core: Katharine Ku, Director of the Office of
Technology Licensing at Stanford University will
present ―Best Practices in University Technology
Transfer‖. Holden Case Study Room, First Floor of

the Farrell Learning and Teaching Center. An
open forum will follow the lecture to capitalize
on this opportunity to collaborate with another
CTSA site (Stanford Center for Clinical & Translational Education and Research)
-November 24 (3:30—4:30 pm): Center for
Clinical Research Ethics: Ana Iltis, PhD, Assistant Professor in the Department of Health
Care Ethics at Saint Louis University will present a lecture entitled ―Participants’ understanding of risks: Improving communication‖ in
Farrell conference Room #1 of the Center for
Advanced Medicine Building.

Investigators using
ICTS Cores & Services
to support their research
should acknowledge the
CTSA Grant
UL1 RR024992
Scholars and Trainees
should acknowledge the
appropriate CTSA
Linked Grant
KL2 RR024994 or
TL1 RR024995
The funding
acknowledgement
statement is posted on
the ICTS website.

I n s t i t u t e of Cl i n i c al &
T r a nsl a t i o nal S c i e n c es
Washington University School of Medicine
Box 8066
660 South Euclid Ave
St. Louis, MO 63110-1010

Phone: 314-362-9829
Fax: 314-362-8015
E-mail: icts.im.wustl.edu

We’re On the Web!
icts.wustl.edu

IN THE NEWS:
Donna Jeffe, PhD, research associate professor in the Division of Health Behavior Research and
Director of the ICTS Tracking & Evaluation Program senior author of ―Characteristics and career intentions of the emerging MD/PhD workforce‖ published in the September 10th issue of the Journal of the
American Medical Association. (PMID: 18780845) See the article in the October 2nd issue of The
Record.
The local chapter of the American Parkinson Disease Association (APDA) hosted their 13 th annual
fundraiser on October 13th. Our own Dr. Joel Perlmutter, director of the Brain, Behavior, Performance
Unit, was one of the St. Louis ―celebrities‖ that walked the runway to raise money for research and
patient services. For more information about the St. Louis Chapter of the APDA, see www.stlapda.org.
Jeffrey I. Gordon, MD has been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive. Dr. Gordon is CoDirector of the ICTS Human Genetics & Genomics Core and the Dr. Robert J. Glaser Distinguished University Professor and director of the Center for Genome Sciences. For more information, see the
article in the October 30th issue of The Record.

CLLINPORTAL,
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biospecimens are key features of caTissue Suite. Together, ClinPortal and caTissue Suite facilitate
collaboration between investigators and data integration across studies. As clinical data becomes
available through the ClinPortal tool, biospecimens referenced in the complementary caTissue Suite
tool will gain increasing clinical annotation, making them even more valuable for translational research
studies.
CBMI provides fully-subsidized support to ICTS members in using both ClinPortal and caTissue Suite.
For more information, send an email to help@cbmi.wustl.edu. Dianne Oliver (see article below) is the
contact for ClinPortal and can be reached at doliver@path.wustl.edu or 314-362-3185. David
Mulvihill, at dmulvihill@wustl.edu or 314-747-6785, can provide assistance with caTissue Suite.

H AV E Y O U M E T ?
DIANNE OLIVER?

Comments about ICTS
News, suggested articles or
questions should be directed
to ICTS@im.wustl.edu or
by contacting Jae Allen at
314-362-9331.

―I love this job. This is such a fast-paced exciting group and many investigators have said ClinPortal is just what they’ve been looking for to
manage their data.‖ Dianne Oliver, Project Manager of ClinPortal with the ICTS Center for Biomedical Informatics (CBMI), is clearly enthusiastic about her work, the people she works with
and the application development she manages.
Rakesh Nagarajan, MD, PhD, Assistant Professor of Pathology & Immunology is Director of the
CBMI. Dianne credits him with being a
―tremendous mentor‖ as she acclimates to her
role.
With an Information Management degree
from Washington University and 8 years experience in the Internal Medicine Division of Oncology, Dianne began managing the ClinPortal project in July of this year. She summarizes her job
as ―leveraging the considerable development
talent in this group to best reach the expected
end results.‖
Those end results currently include one investigator study fully supported in ClinPortal and 18
in process and expected to be in production by
the end of 2008. Dianne notes that they will be
ready to take on additional projects starting in
January, although investigators can call now.
To transition existing clinical studies data to
ClinPortal or establish electronic forms to input

new information, the investigator should first talk with
Dianne. Following a demo
of ClinPortal, Dianne and
the informatics staff work
with the user to discuss any existing data collection forms, information workflow and the advantages and potential limitations of automation
through ClinPortal. Then the informatics personnel create forms. A short iterative process combining user feedback and forms refinement is
used to finalize the study’s representation in ClinPortal.
The system uses a standard data dictionary,
leveraging existing medical terminologies (e.g.
SNOMED-CT and LOINC). Dianne works with technically astute, medically trained staff to assist in
creating an appropriate object model and userfriendly data entry forms for each study. The robust query functionality can search on any data
element and return de-identified or identified data,
depending upon the access rights of the investigator doing the search and the privileges set by the
investigator owning the data. ClinPortal will also
support single sign-on and data sharing with caTissue Suite (see article, page 1).
For more information about ClinPortal, contact
Dianne at doliver@path.wustl.edu or 314-3623185.

BANDER PROGRAM IN BUSINESS ETHICS
IN MEDICAL RESEARCH

HEALTH CARE BAND-AIDS: HOW TO FIX
AMERICA’S AILING HEALTH CARE SYSTEM
EZEKIEL EMANUEL, MD, PHD
CHAIR, DEPARTMENT OF BIOETHICS
NATIONAL INSTITUTES OF HEALTH

THURSDAY, NOVEMBER 6, 2008
6:00 – 7:00 PM
(APPETIZERS 5:15 – 6:00 PM)

CLOPTON AUDITORIUM
(LOWER LEVEL WOHL CLINIC BUILDING)
RSVP REQUESTED BUT NOT REQUIRED BY OCTOBER 31 TO:
MARY FAVAZZA, 314-454-8224 OR MFAVAZZA@IM.WUSTL.EDU

WWW.ICTS.WUSTL.EDU
ICTS Partner Organizations
Washington University; Saint Louis University –Graduate School –School of Public Health –Doisy College of
Health Sciences –School of Nursing; St. Louis College of Pharmacy; University of Missouri at St. Louis
College of Nursing; Southern Illinois University Edwardsville School of Nursing; BJC Health System
including –Barnes-Jewish Hospital –St. Louis Children’s Hospital –Goldfarb School of Nursing; Key
organizations promoting community health; Biomedical and pharmaceutical companies in the St. Louis Area.
Primary funding through the NIH/NCRR Clinical & Translational Science Award Program UL1 RR024992

Special Address and Open Forum
“Best Practices in University Technology Transfer”

Katharine Ku
Director,
Office of Technology Licensing
Stanford University

Monday, November 24, 2008
3:00 PM—5:30 PM
Holden Case Study Room on the First Floor
—Farrell Learning and Teaching Center, 520 S. Euclid
Washington University Medical School Campus
Open Forum Following the Address
Moderator: Samuel L. Stanley, Jr., M.D., Vice Chancellor for Research
Panelists:
Katharine Ku, Director, Office of Technology Licensing, Stanford
Bradley Castanho, Co-Director, Office of Technology Management
Michael Marrah, Co-Director, Office of Technology Management
Reception at 5:30 PM in the
Hearth Room on the Second Floor
—Farrell Learning and Teaching Center

